Atlas Trials

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Clinical trial NCT03059381 · COMPLETED

Trial details

NCT number
NCT03059381
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Start date
2016-08-01
Primary completion
2021-03-21
Enrollment
519

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.